Furthermore, 5/6-Nx mice showed hyperphosphatemia, increased total serum alkaline phosphatase (ALP) activity, severe secondary hyperparathyroidism, and elevated serum intact Fgf23 levels, relative to Sham controls (Figure 1A). The gene discussed is FGF23; the disease is hyperphosphatemia.